HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo.

AuthorsWei Deng, Yanfeng Xu, Qi Kong, Jing Xue, Pin Yu, Jiangning Liu, Qi Lv, Fengdi Li, Qiang Wei, Linlin Bao
JournalSignal transduction and targeted therapy (Signal Transduct Target Ther) Vol. 5 Issue 1 Pg. 66 (05 08 2020) ISSN: 2059-3635 [Electronic] England
PMID32385228 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiviral Agents
  • Drugs, Chinese Herbal
  • Pudilan xiaoyan
Topics
  • Animals
  • Antiviral Agents (pharmacology, therapeutic use)
  • Betacoronavirus (drug effects)
  • COVID-19
  • Chlorocebus aethiops
  • Coronavirus Infections (drug therapy)
  • Disease Models, Animal
  • Drugs, Chinese Herbal (pharmacology, therapeutic use)
  • Mice
  • Pandemics
  • Pneumonia, Viral (drug therapy)
  • Random Allocation
  • SARS-CoV-2
  • Treatment Outcome
  • Vero Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: